Israeli biotech co Nectin Therapeutics raises $10m

Nectin develops novel targeted immunotherapies that address resistance to approved immune oncology treatments.

Related Keywords

Israel ,Guangzhou ,Guangdong ,China ,Israeli ,Fabian Tenenbaum ,Moon Fund ,Cancer Focus Fund ,Israel Biotechnology Fund ,Integra Holdings ,Myeloma Investment Fund ,Guangzhou Israel Biotechnology Fund ,Peregrine Ventures ,Cancer Focus ,